Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: Patient prognosis and risk-factors for colonisation and infection

Clinical Microbiology and Infection

Volumn 11, Issue 7, 2005, Pages 540-546

  del Mar Tomas, M ^a   Cartelle, M ^a   Pertega, S ^a   Beceiro, A ^a   Llinares, P ^a   Canle, D ^a   Molina, F ^a   Villanueva, R ^a   Cisneros, J M ^b   Bou, German ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; Colonisation; Infection; Nosocomial outbreak; Risk factors

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ARTERY CATHETER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; EPIDEMIC; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; HYPOTENSION; INTUBATION; LOGISTIC REGRESSION ANALYSIS; MALE; MONOTHERAPY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SHOCK; TRACHEOSTOMY;

ACINETOBACTER BAUMANNII;

EID: 21244471489     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01184.x     Document Type: Article

References (26)

1. Cisneros JM, Reyes MJ, Pachón J et al. Bacteriemia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996; 22: 1026-1032.
2. García Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis 2001; 33: 939-946.
3. Gomez J, Simarro E, Banos V et al. Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 1999; 18: 358-361.
4. Wisplinghoff H, Edmond MB, Pfaller MA et al. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospital: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 2000; 31: 690-670.
5. Corbella X, Montero A, Pujol M et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000; 38: 4086-4095.
6. Montero A, Ariza J, Corbella X et al. Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob Agents Chemother 2002; 46: 1946-1952.
7. Bou G, Cervero G, Dominguez MA et al. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J Clin Microbiol 2000; 38: 3299-3305.
8. Corbella X, Ariza J, Ardanuy C et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother 1998; 42: 793-802.
9. Jellison TK, Mckinnon PS. Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam. Pharmacotherapy 2001; 21: 142-148.
10. Levin AS. Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem. Clin Microbiol Infect 2002; 8: 144-153.
11. Levin AS, Levy CE, Manrique AE et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents 2003; 21: 58-62.
12. Levin AS. Treatment of Acinetobacter spp. infections. Expert Opin Pharmacother 2003; 4: 1289-1296.
13. Giamarellos-Bourboulis EJ, Xirouchaki E, Giamarellou H. Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 2001; 40: 117-120.
14. Levin AS, Barone AA, Penco J et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999; 28: 1008-1011.
15. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Cont Hosp Epidemiol 2003; 24: 284-295.
16. Lee SO, Kim NJ, Choi SH et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004; 48: 224-228.
17. Roberts SA, Findlay R, Lang SDR. Investigation of outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect 2001; 48: 228-232.
18. Vaneechoutte M, Dijkshoorn L, Tjernberg A et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 1995; 33: 11-15.
19. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne, PA: NCCLS, 2003.
20. Bou G, Cervero G, Domínguez MA et al. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect 2000; 6: 635-643.
21. Martin-Lozano D, Cisneros JM, Becerril B et al. Comparison of a repetitive extragenic palindromic sequence based PCR method and clinical and microbiological methods for determining strain sources in cases of nosocomial Acinetobacter baumannii bacteremia. J Clin Microbiol 2002; 40: 4571-4575.
22. Quelle LS, Catalano M. Efficacy of two DNA fingerprinting methods for typing Acinetobacter baumannii isolates. Diagn Microbiol Infect Dis 2001; 39: 215-223.
23. Anonymous. ATC index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2001.
24. Villers D, Espaze E, Coste-Burel M et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 1998; 129: 182-189.
25. Das I, Lambert P, Hill D et al. Carbapenem-resistant Acinetobacter and role of curtains in outbreaks in intensive care units. J Hosp Infect 2002; 50: 110-114.
26. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002; 8: 687-693.